Publications by authors named "Mathieu Cinier"

Claim this Profile
I
Investigating probe-receptor interactions and enhancing fluorescence guided surgery with fluorescence lifetime imaging and NF-800 in HER-2 positive esophageal adenocarcinoma.
Francesca La Cava, Francesca Arena, Daniele Faletto, Margherita Iaboni, Federico Crivellin, Mathieu Cinier

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice.
Perrine Jacquot, Javier Muñoz-Garcia, Antoine Léger, Antoine Babuty, Manon Taupin, Mathieu Cinier

Biomolecules· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model.
Simon Huet, Magali Zeisser Labouebe, Rute Castro, Perrine Jacquot, Jessy Pedrault, Mathieu Cinier

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract.
Sébastien Viollet, Elise Enouf, Justine Picot, Léna Noël, Simon Huet, Mathieu Cinier

Mol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1.
Perrine Jacquot, Javier Muñoz-Garcia, Maurine Fleury, Denis Cochonneau, Rémi Gaussin, Mathieu Cinier

Biomolecules· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin binding Nanofitins, a new scaffold to extend half-life of biologics - a case study with exenatide peptide.
Nadine Michot, Aurélia Guyochin, Mathieu Cinier, Chloé Savignard, Olivier Kitten

Peptides· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of APL-1030, a Novel, High-Affinity Nanofitin Inhibitor of C3-Mediated Complement Activation.
Joshua Garlich, Mathieu Cinier, Anne Chevrel, Anaëlle Perrocheau, David J Eyerman

Biomolecules· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer.
Guillaume Marcion, François Hermetet, Fabrice Neiers, Burhan Uyanik, Lucile Dondaine, Mathieu Cinier

Int J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.
Marine Goux, Guillaume Becker, Harmony Gorré, Sylvestre Dammicco, Ariane Desselle, Mathieu Cinier

Bioconjug Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [F]FBEM and in vivo PET studies.
Sylvestre Dammicco, Marine Goux, Christian Lemaire, Guillaume Becker, Mohamed Ali Bahri, Mathieu Cinier

Nucl Med Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion Tag.
Simon Huet, Harmony Gorre, Anaëlle Perrocheau, Justine Picot, Mathieu Cinier

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo phosphorylation of a peptide tag for protein purification.
Marine Goux, Amina Fateh, Alain Defontaine, Mathieu Cinier, Charles Tellier

Biotechnol Lett· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
Peixuan Guo, Yi Shu, Daniel Binzel, Mathieu Cinier

Methods Mol Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of a phosphorylatable tag for specific protein binding on zirconium phosphonate based microarrays.
Mathieu Cinier, Marc Petit, Frédéric Pecorari, Daniel R Talham, Bruno Bujoli

J Biol Inorg Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
Yi Shu, Mathieu Cinier, Sejal R Fox, Nira Ben-Johnathan, Peixuan Guo

Mol Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
Yi Shu, Mathieu Cinier, Dan Shu, Peixuan Guo

Methods· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging.
Jing Liu, Songchuan Guo, Mathieu Cinier, Luda S Shlyakhtenko, Yi Shu

ACS Nano· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate adaptors for specific protein binding on zirconium phosphonate-based microarrays.
Mathieu Cinier, Marc Petit, Monique N Williams, Roxane M Fabre, Frédéric Pecorari

Bioconjug Chem· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis